Mike Trower
9Patents
3h-index
5Co-inventors
42Inventor score
Filing activity: May 18, 2016 → Jul 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10195205B2 | Uses of dual NK1/NK3 receptor antagonists for treating sex-hormone diseases | Human Necessities | 4 | Active |
| US10774091B2 | Soft gelatin capsule formulation | Chemistry; Metallurgy | 3 | Active |
| US11591346B2 | Method of treatment of symptoms of menopause | Chemistry; Metallurgy | 3 | Active |
| US11787820B2 | Method of treating certain sex hormone-dependent diseases administering a soft gelatin capsule comprising NK1 and NK3 receptors antagonists | Chemistry; Metallurgy | 1 | Active |
| US9750739B2 | Orvepitant for chronic cough therapy | Human Necessities | 1 | Active |
| US11767328B2 | Method of treatment of symptoms of menopause | Chemistry; Metallurgy | 1 | Active |
| US12264164B2 | Method of treatment of symptoms of menopause | Chemistry; Metallurgy | 0 | Active |
| US9907795B2 | Method of treatment of chronic cough administering orvepitant in combination with other therapeutic agents | Human Necessities | 0 | Active |
| US11872222B2 | Uses | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.